{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:24:59Z","timestamp":1793269499123,"version":"4.5.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["R01AG078615"],"award-info":[{"award-number":["R01AG078615"]}]},{"name":"Florida Department of Health Ed and Ethel Moore Alzheimer\u2019s Disease Research Program","award":["24A07"],"award-info":[{"award-number":["24A07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s12035-025-04866-w","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:45:16Z","timestamp":1742863516000},"page":"9573-9585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological Disorders"],"prefix":"10.1007","volume":"62","author":[{"given":"Yonghe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Izhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"4866_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15:501\u2013518","journal-title":"Nat Rev Neurol"},{"key":"4866_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00420-5","volume":"16","author":"J Cummings","year":"2021","unstructured":"Cummings J (2021) New approaches to symptomatic treatments for Alzheimer\u2019s disease. Mole Neurodegen 16:1","journal-title":"Mole Neurodegen"},{"key":"4866_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer\u2019s disease: targeting the cholinergic system. Curr Neuropharmacol 14:101\u2013115","journal-title":"Curr Neuropharmacol"},{"key":"4866_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102203","volume":"94","author":"I Terao","year":"2024","unstructured":"Terao I, Kodama W (2024) Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer\u2019s disease: A systematic review and network meta-analysis. Ageing Res Rev 94:102203","journal-title":"Ageing Res Rev"},{"key":"4866_CR5","first-page":"ENEURO0319-23.2","volume":"11","author":"AJ Espay","year":"2024","unstructured":"Espay AJ, Kepp KP, Herrup K (2024) Lecanemab and Donanemab as Therapies for Alzheimer\u2019s Disease: An Illustrated Perspective on the Data. Neuro 11:ENEURO0319-23.2024","journal-title":"Neuro"},{"key":"4866_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW (2014) Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 13:673\u2013691","journal-title":"Nat Rev Drug Discov"},{"key":"4866_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.conb.2020.08.011","volume":"67","author":"AM Burns","year":"2021","unstructured":"Burns AM, Graff J (2021) Cognitive epigenetic priming: leveraging histone for amelioration. Curr Opin Neurobiol 67:75\u201384","journal-title":"Curr Opin Neurobiol"},{"key":"4866_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1021\/acschemneuro.1c00775","volume":"13","author":"PC Pao","year":"2022","unstructured":"Pao PC, Tsai LH (2022) Histone Deacetylases 1 and 2 in Memory Function. ACS Chem Neurosci 13:848\u2013858","journal-title":"ACS Chem Neurosci"},{"key":"4866_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S (2022) Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol 20:158\u2013178","journal-title":"Curr Neuropharmacol"},{"key":"4866_CR10","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","volume":"26","author":"XJ Yang","year":"2007","unstructured":"Yang XJ, Seto E (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310\u20135318","journal-title":"Oncogene"},{"key":"4866_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 6:a018713","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4866_CR12","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1111\/bcp.14889","volume":"87","author":"AD Bondarev","year":"2021","unstructured":"Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schioth HB (2021) Recent developments of HDAC inhibitors: Emerging indications and novel molecules. Br J Clin Pharmacol 87:4577\u20134597","journal-title":"Br J Clin Pharmacol"},{"key":"4866_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.conb.2020.08.011","volume":"67","author":"AM Burns","year":"2021","unstructured":"Burns AM, Graff J (2021) Cognitive epigenetic priming: leveraging histone acetylation for memory amelioration. Curr Opin Neurobiol 67:75\u201384","journal-title":"Curr Opin Neurobiol"},{"key":"4866_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-017-0089-1","volume":"6","author":"SS Yang","year":"2017","unstructured":"Yang SS, Zhang R, Wang G, Zhang YF (2017) The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease. Transl Neurodegener 6:1","journal-title":"Transl Neurodegener"},{"key":"4866_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102003","volume":"90","author":"D Jeremic","year":"2023","unstructured":"Jeremic D, Jimenez-Diaz L, Navarro-Lopez JD (2023) Targeting epigenetics: A novel promise for Alzheimer\u2019s disease treatment. Ageing Res Rev 90:102003","journal-title":"Ageing Res Rev"},{"key":"4866_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2533\/chimia.2022.448","volume":"76","author":"E Di Bello","year":"2022","unstructured":"Di Bello E, Noce B, Fioravanti R, Mai A (2022) Current HDAC Inhibitors in clinical trials. Chimia (Aarau) 76:448\u2013453","journal-title":"Chimia (Aarau)"},{"key":"4866_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1387\/ijdb.082649rb","volume":"53","author":"R Brunmeir","year":"2009","unstructured":"Brunmeir R, Lagger S, Seiser C (2009) Histone deacetylase 1 and 2-controlled embryonic development and cell differentiation. Int J Dev Biol 53:275\u2013289","journal-title":"Int J Dev Biol"},{"key":"4866_CR18","doi-asserted-by":"publisher","first-page":"28001","DOI":"10.1074\/jbc.272.44.28001","volume":"272","author":"WM Yang","year":"1997","unstructured":"Yang WM, Yao YL, Sun JM, Davie JR, Seto E (1997) Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family. J Biol Chem 272:28001\u201328007","journal-title":"J Biol Chem"},{"key":"4866_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1006\/bbrc.1997.8033","volume":"242","author":"F Dangond","year":"1998","unstructured":"Dangond F, Hafler DA, Tong JK, Randall J, Kojima R, Utku N, Gullans SR (1998) Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem Biophys Res Commun 242:648\u2013652","journal-title":"Biochem Biophys Res Commun"},{"key":"4866_CR20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","volume":"12","author":"JR Somoza","year":"2004","unstructured":"Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A et al (2004) Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12:1325\u20131334","journal-title":"Structure"},{"key":"4866_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tips.2015.04.013","volume":"36","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Oehme I, Witt O, Oliveira G, Sippl W, Romier C, Pierce RJ, Jung M (2015) HDAC8: a multifaceted target for therapeutic interventions. Trends Pharmacol Sci 36:481\u2013492","journal-title":"Trends Pharmacol Sci"},{"key":"4866_CR22","doi-asserted-by":"publisher","first-page":"9447","DOI":"10.1074\/jbc.M105993200","volume":"277","author":"WM Yang","year":"2002","unstructured":"Yang WM, Tsai SC, Wen YD, Fejer G, Seto E (2002) Functional domains of histone deacetylase-3. J Biol Chem 277:9447\u20139454","journal-title":"J Biol Chem"},{"key":"4866_CR23","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1038\/sj.onc.1210612","volume":"26","author":"P Karagianni","year":"2007","unstructured":"Karagianni P, Wong J (2007) HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene 26:5439\u20135449","journal-title":"Oncogene"},{"key":"4866_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bbapap.2012.08.009","volume":"1834","author":"S Kalyaanamoorthy","year":"2013","unstructured":"Kalyaanamoorthy S, Chen YP (2013) Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes. Biochim Biophys Acta 1834:317\u2013328","journal-title":"Biochim Biophys Acta"},{"key":"4866_CR25","doi-asserted-by":"publisher","first-page":"112171","DOI":"10.1016\/j.ejmech.2020.112171","volume":"192","author":"R Sarkar","year":"2020","unstructured":"Sarkar R, Banerjee S, Amin SA, Adhikari N, Jha T (2020) Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review. Eur J Med Chem 192:112171","journal-title":"Eur J Med Chem"},{"key":"4866_CR26","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1021\/acs.jmedchem.0c01676","volume":"64","author":"N Adhikari","year":"2021","unstructured":"Adhikari N, Jha T, Ghosh B (2021) Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy. J Med Chem 64:8827\u20138869","journal-title":"J Med Chem"},{"key":"4866_CR27","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1073\/pnas.1213364110","volume":"110","author":"M Malvaez","year":"2013","unstructured":"Malvaez M, McQuown SC, Rogge GA, Astarabadi M, Jacques V, Carreiro S, Rusche JR, Wood MA (2013) HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci U S A 110:2647\u20132652","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4866_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102684","volume":"9","author":"KM Barton","year":"2014","unstructured":"Barton KM, Archin NM, Keedy KS, Espeseth AS, Zhang YL, Gale J, Wagner FF, Holson EB et al (2014) Selective HDAC inhibition for the disruption of latent HIV-1 infection. PLoS ONE 9:e102684","journal-title":"PLoS ONE"},{"key":"4866_CR29","doi-asserted-by":"publisher","first-page":"109633","DOI":"10.1016\/j.neuropharm.2023.109633","volume":"237","author":"Y Li","year":"2023","unstructured":"Li Y, Liu C, Wang G, Wang H, Liu X, Huang C, Chen Y, Fan L et al (2023) HDAC3 inhibitor (BRD3308) modulates microglial pyroptosis and neuroinflammation through PPARgamma\/NLRP3\/GSDMD to improve neurological function after intraventricular hemorrhage in mice. Neuropharmacology 237:109633","journal-title":"Neuropharmacology"},{"key":"4866_CR30","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/leu.2013.231","volume":"28","author":"J Minami","year":"2014","unstructured":"Minami J, Suzuki R, Mazitschek R, Gorgun G, Ghosh B, Cirstea D, Hu Y, Mimura N et al (2014) Histone deacetylase 3 as a novel therapeutic target in multiple myeloma. Leukemia 28:680\u2013689","journal-title":"Leukemia"},{"key":"4866_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1021\/acschemneuro.0c00721","volume":"12","author":"S Pulya","year":"2021","unstructured":"Pulya S, Mahale A, Bobde Y, Routholla G, Patel T, Swati BS, Sharma V, Kulkarni OP et al (2021) PT3: A Novel Benzamide Class Histone Deacetylase 3 inhibitor improves learning and memory in novel object recognition mouse model. ACS Chem Neurosci 12:883\u2013892","journal-title":"ACS Chem Neurosci"},{"key":"4866_CR32","doi-asserted-by":"publisher","first-page":"re12","DOI":"10.1126\/scisignal.aaa0069","volume":"7","author":"J Penney","year":"2014","unstructured":"Penney J, Tsai LH (2014) Histone deacetylases in memory and cognition. Sci Signal 7:re12","journal-title":"Sci Signal"},{"key":"4866_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/npp.2012.86","volume":"38","author":"L Peixoto","year":"2013","unstructured":"Peixoto L, Abel T (2013) The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 38:62\u201376","journal-title":"Neuropsychopharmacology"},{"key":"4866_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148951","volume":"1837","author":"BM McClarty","year":"2024","unstructured":"McClarty BM, Rodriguez G, Dong H (2024) Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP\/PS1 mice. Brain Res 1837:148951","journal-title":"Brain Res"},{"key":"4866_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1101\/lm.046920.117","volume":"25","author":"G Shu","year":"2018","unstructured":"Shu G, Kramar EA, Lopez AJ, Huynh G, Wood MA, Kwapis JL (2018) Deleting HDAC3 rescues long-term memory impairments induced by disruption of the neuron-specific chromatin remodeling subunit BAF53b. Learn Mem 25:109\u2013114","journal-title":"Learn Mem"},{"key":"4866_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","volume":"31","author":"SC McQuown","year":"2011","unstructured":"McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, Mullican SE, Jones S et al (2011) HDAC3 Is a critical negative regulator of long-term memory formation. J Neurosci 31:764\u2013774","journal-title":"J Neurosci"},{"key":"4866_CR37","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1038\/s41467-018-05868-0","volume":"9","author":"JL Kwapis","year":"2018","unstructured":"Kwapis JL, Alaghband Y, Kramar EA, Lopez AJ, Vogel Ciernia A, White AO, Shu G, Rhee D et al (2018) Epigenetic regulation of the circadian gene Per1 contributes to age-related changes in hippocampal memory. Nat Commun 9:3323","journal-title":"Nat Commun"},{"key":"4866_CR38","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, Xu Y (2017) HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease. Aging Cell 16:1073\u20131082","journal-title":"Aging Cell"},{"key":"4866_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nlm.2014.06.008","volume":"114","author":"AV Franklin","year":"2014","unstructured":"Franklin AV, Rusche JR, McMahon LL (2014) Increased long-term potentiation at medial-perforant path-dentate granule cell synapses induced by selective inhibition of histone deacetylase 3 requires Fragile X mental retardation protein. Neurobiol Learn Mem 114:193\u2013197","journal-title":"Neurobiol Learn Mem"},{"key":"4866_CR40","doi-asserted-by":"publisher","first-page":"16616","DOI":"10.1038\/srep16616","volume":"5","author":"M Sharma","year":"2015","unstructured":"Sharma M, Shetty MS, Arumugam TV, Sajikumar S (2015) Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B. Sci Rep 5:16616","journal-title":"Sci Rep"},{"key":"4866_CR41","doi-asserted-by":"publisher","first-page":"9192","DOI":"10.1523\/JNEUROSCI.0691-21.2021","volume":"41","author":"EK Rotondo","year":"2021","unstructured":"Rotondo EK, Bieszczad KM (2021) Memory specific to temporal features of sound is formed by cue-selective enhancements in temporal coding enabled by inhibition of an epigenetic regulator. J Neurosci 41:9192\u20139209","journal-title":"J Neurosci"},{"key":"4866_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/j.pain.0000000000002056","volume":"162","author":"GF Zhang","year":"2021","unstructured":"Zhang GF, Zhou ZQ, Guo J, Gu HW, Su MZ, Yu BC, Zhou F, Han BY et al (2021) Histone deacetylase 3 in hippocampus contributes to memory impairment after chronic constriction injury of sciatic nerve in mice. Pain 162:382\u2013395","journal-title":"Pain"},{"key":"4866_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2022.114002","volume":"433","author":"L Yang","year":"2022","unstructured":"Yang L, Hao JR, Gao Y, Yang X, Shen XR, Wang HY, Sun N, Gao C (2022) HDAC3 of dorsal hippocampus induces postoperative cognitive dysfunction in aged mice. Behav Brain Res 433:114002","journal-title":"Behav Brain Res"},{"key":"4866_CR44","doi-asserted-by":"publisher","first-page":"13124","DOI":"10.1523\/JNEUROSCI.0914-15.2015","volume":"35","author":"KM Bieszczad","year":"2015","unstructured":"Bieszczad KM, Bechay K, Rusche JR, Jacques V, Kudugunti S, Miao W, Weinberger NM, McGaugh JL et al (2015) Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation. J Neurosci 35:13124\u201313132","journal-title":"J Neurosci"},{"key":"4866_CR45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbr.2018.05.036","volume":"356","author":"A Shang","year":"2019","unstructured":"Shang A, Bylipudi S, Bieszczad KM (2019) Inhibition of histone deacetylase 3 via RGFP966 facilitates cortical plasticity underlying unusually accurate auditory associative cue memory for excitatory and inhibitory cue-reward associations. Behav Brain Res 356:453\u2013469","journal-title":"Behav Brain Res"},{"key":"4866_CR46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1523\/JNEUROSCI.1604-18.2018","volume":"39","author":"GC Sartor","year":"2019","unstructured":"Sartor GC, Malvezzi AM, Kumar A, Andrade NS, Wiedner HJ, Vilca SJ, Janczura KJ, Bagheri A et al (2019) Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins. J Neurosci 39:612\u2013626","journal-title":"J Neurosci"},{"key":"4866_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.brainresbull.2021.01.016","volume":"169","author":"EK Rotondo","year":"2021","unstructured":"Rotondo EK, Bieszczad KM (2021) Sensory cortical and subcortical auditory neurophysiological changes predict cue-specific extinction behavior enabled by the pharmacological inhibition of an epigenetic regulator during memory formation. Brain Res Bull 169:167\u2013183","journal-title":"Brain Res Bull"},{"key":"4866_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00213-018-5122-2","volume":"236","author":"LN Hitchcock","year":"2019","unstructured":"Hitchcock LN, Raybuck JD, Wood MA, Lattal KM (2019) Effects of a histone deacetylase 3 inhibitor on extinction and reinstatement of cocaine self-administration in rats. Psychopharmacology 236:517\u2013529","journal-title":"Psychopharmacology"},{"key":"4866_CR49","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1523\/JNEUROSCI.2799-18.2019","volume":"39","author":"JL Kwapis","year":"2019","unstructured":"Kwapis JL, Alaghband Y, Lopez AJ, Long JM, Li X, Shu G, Bodinayake KK, Matheos DP et al (2019) HDAC3-Mediated Repression of the Nr4a Family Contributes to Age-Related Impairments in Long-Term Memory. J Neurosci 39:4999\u20135009","journal-title":"J Neurosci"},{"key":"4866_CR50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","volume":"38","author":"P Kowianski","year":"2018","unstructured":"Kowianski P, Lietzau G, Czuba E, Waskow M, Steliga A, Morys J (2018) BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity. Cell Mol Neurobiol 38:579\u2013593","journal-title":"Cell Mol Neurobiol"},{"key":"4866_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2007.08.021","volume":"56","author":"JI Wu","year":"2007","unstructured":"Wu JI, Lessard J, Olave IA, Qiu Z, Ghosh A, Graef IA, Crabtree GR (2007) Regulation of dendritic development by neuron-specific chromatin remodeling complexes. Neuron 56:94\u2013108","journal-title":"Neuron"},{"key":"4866_CR52","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1101\/gad.992102","volume":"16","author":"I Olave","year":"2002","unstructured":"Olave I, Wang W, Xue Y, Kuo A, Crabtree GR (2002) Identification of a polymorphic, neuron-specific chromatin remodeling complex. Genes Dev 16:2509\u20132517","journal-title":"Genes Dev"},{"key":"4866_CR53","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nn.3359","volume":"16","author":"A Vogel-Ciernia","year":"2013","unstructured":"Vogel-Ciernia A, Matheos DP, Barrett RM, Kramar EA, Azzawi S, Chen Y, Magnan CN, Zeller M et al (2013) The neuron-specific chromatin regulatory subunit BAF53b is necessary for synaptic plasticity and memory. Nat Neurosci 16:552\u2013561","journal-title":"Nat Neurosci"},{"key":"4866_CR54","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1101\/lm.044602.116","volume":"24","author":"A Vogel Ciernia","year":"2017","unstructured":"Vogel Ciernia A, Kramar EA, Matheos DP, Havekes R, Hemstedt TJ, Magnan CN, Sakata K, Tran A et al (2017) Mutation of neuron-specific chromatin remodeling subunit BAF53b: rescue of plasticity and memory by manipulating actin remodeling. Learn Mem 24:199\u2013209","journal-title":"Learn Mem"},{"key":"4866_CR55","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/npp.2016.253","volume":"42","author":"MS Bridi","year":"2017","unstructured":"Bridi MS, Hawk JD, Chatterjee S, Safe S, Abel T (2017) Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB\/CBP-Dependent Manner. Neuropsychopharmacology 42:1243\u20131253","journal-title":"Neuropsychopharmacology"},{"key":"4866_CR56","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1172\/JCI64145","volume":"122","author":"JD Hawk","year":"2012","unstructured":"Hawk JD, Bookout AL, Poplawski SG, Bridi M, Rao AJ, Sulewski ME, Kroener BT, Manglesdorf DJ et al (2012) NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. J Clin Invest 122:3593\u20133602","journal-title":"J Clin Invest"},{"key":"4866_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.786226","volume":"14","author":"J Catala-Solsona","year":"2021","unstructured":"Catala-Solsona J, Minano-Molina AJ, Rodriguez-Alvarez J (2021) Nr4a2 Transcription factor in hippocampal synaptic plasticity, memory and cognitive dysfunction: a perspective review. Front Mol Neurosci 14:786226","journal-title":"Front Mol Neurosci"},{"key":"4866_CR58","doi-asserted-by":"publisher","first-page":"6238989","DOI":"10.1155\/2018\/6238989","volume":"2018","author":"O Rawashdeh","year":"2018","unstructured":"Rawashdeh O, Parsons R, Maronde E (2018) Clocking in time to gate memory processes: the circadian clock is part of the ins and outs of memory. Neural Plast 2018:6238989","journal-title":"Neural Plast"},{"key":"4866_CR59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/cge.13075","volume":"93","author":"M Mila","year":"2018","unstructured":"Mila M, Alvarez-Mora MI, Madrigal I, Rodriguez-Revenga L (2018) Fragile X syndrome: An overview and update of the FMR1 gene. Clin Genet 93:197\u2013205","journal-title":"Clin Genet"},{"key":"4866_CR60","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger BN, Dickson DW (2017) Pathology of Neurodegenerative Diseases. Cold Spring Harb Perspect Biol 9:a028035","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4866_CR61","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1523\/JNEUROSCI.5704-10.2011","volume":"31","author":"FH Bardai","year":"2011","unstructured":"Bardai FH, D\u2019Mello SR (2011) Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. J Neurosci 31:1746\u20131751","journal-title":"J Neurosci"},{"key":"4866_CR62","doi-asserted-by":"publisher","first-page":"35444","DOI":"10.1074\/jbc.M112.394544","volume":"287","author":"FH Bardai","year":"2012","unstructured":"Bardai FH, Price V, Zaayman M, Wang LL, D\u2019Mello SR (2012) Histone Deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death. J Biol Chem 287:35444\u201335453","journal-title":"J Biol Chem"},{"key":"4866_CR63","doi-asserted-by":"publisher","first-page":"34266","DOI":"10.1074\/jbc.M006160200","volume":"275","author":"RJ Crowder","year":"2000","unstructured":"Crowder RJ, Freeman RS (2000) Glycogen synthase kinase-3\u03b2 activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J Biol Chem 275:34266\u201334271","journal-title":"J Biol Chem"},{"key":"4866_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratico D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Cell Res 1867:118664","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4866_CR65","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/ALN.0000000000000278","volume":"121","author":"G Tao","year":"2014","unstructured":"Tao G, Zhang J, Zhang L, Dong Y, Yu B, Crosby G, Culley DJ, Zhang Y et al (2014) Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3beta activation in young mice. Anesthesiology 121:510\u2013527","journal-title":"Anesthesiology"},{"key":"4866_CR66","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s42003-021-02047-8","volume":"4","author":"Y Dong","year":"2021","unstructured":"Dong Y, Liang F, Huang L, Fang F, Yang G, Tanzi RE, Zhang Y, Quan Q et al (2021) The anesthetic sevoflurane induces tau trafficking from neurons to microglia. Commun Biol 4:560","journal-title":"Commun Biol"},{"key":"4866_CR67","doi-asserted-by":"crossref","unstructured":"Zhou J, Feng X, Wang D (2023) HDAC3 deacetylates H3K27ac and H3K9ac on the TrkC promoter to exacerbate sevoflurane-induced neurotoxicity. Mole Cell Toxicol","DOI":"10.1007\/s13273-023-00394-7"},{"key":"4866_CR68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1124\/jpet.114.219345","volume":"352","author":"L Formisano","year":"2015","unstructured":"Formisano L, Guida N, Laudati G, Mascolo L, Di Renzo G, Canzoniero LM (2015) MS-275 inhibits aroclor 1254-induced SH-SY5Y neuronal cell toxicity by preventing the formation of the HDAC3\/REST complex on the synapsin-1 promoter. J Pharmacol Exp Ther 352:236\u2013243","journal-title":"J Pharmacol Exp Ther"},{"key":"4866_CR69","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405","journal-title":"Lancet Neurol"},{"key":"4866_CR70","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12974-024-03024-8","volume":"21","author":"W Balestri","year":"2024","unstructured":"Balestri W, Sharma R, da Silva VA, Bobotis BC, Curle AJ, Kothakota V, Kalantarnia F, Hangad MV et al (2024) Modeling the neuroimmune system in Alzheimer\u2019s and Parkinson\u2019s diseases. J Neuroinflammation 21:32","journal-title":"J Neuroinflammation"},{"key":"4866_CR71","doi-asserted-by":"publisher","first-page":"e10248","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11:e10248","journal-title":"EMBO Mol Med"},{"key":"4866_CR72","first-page":"4368","volume":"127","author":"R Kanski","year":"2014","unstructured":"Kanski R, Sneeboer MA, van Bodegraven EJ, Sluijs JA, Kropff W, Vermunt MW, Creyghton MP, De Filippis L et al (2014) Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. J Cell Sci 127:4368\u20134380","journal-title":"J Cell Sci"},{"key":"4866_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.brainres.2008.05.085","volume":"1226","author":"B Zhang","year":"2008","unstructured":"Zhang B, West EJ, Van KC, Gurkoff GG, Zhou J, Zhang XM, Kozikowski AP, Lyeth BG (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res 1226:181\u2013191","journal-title":"Brain Res"},{"key":"4866_CR74","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nbd.2009.07.019","volume":"36","author":"G Faraco","year":"2009","unstructured":"Faraco G, Pittelli M, Cavone L, Fossati S, Porcu M, Mascagni P, Fossati G, Moroni F et al (2009) Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo. Neurobiol Dis 36:269\u2013279","journal-title":"Neurobiol Dis"},{"key":"4866_CR75","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.bbi.2018.09.019","volume":"74","author":"G Rigillo","year":"2018","unstructured":"Rigillo G, Vilella A, Benatti C, Schaeffer L, Brunello N, Blom JMC, Zoli M, Tascedda F (2018) LPS-induced histone H3 phospho(Ser10)-acetylation(Lys14) regulates neuronal and microglial neuroinflammatory response. Brain Behav Immun 74:277\u2013290","journal-title":"Brain Behav Immun"},{"key":"4866_CR76","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41593-024-01580-z","volume":"27","author":"BLL Clayton","year":"2024","unstructured":"Clayton BLL, Kristell JD, Allan KC, Cohn EF, Karl M, Jerome AD, Garrison E, Maeno-Hikichi Y et al (2024) A phenotypic screening platform for identifying chemical modulators of astrocyte reactivity. Nat Neurosci 27:656","journal-title":"Nat Neurosci"},{"key":"4866_CR77","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-022-02563-2","volume":"19","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Mu H, Huang Y, Li S, Wang Y, Stetler RA, Bennett MVL, Dixon CE et al (2022) Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury. J Neuroinflammation 19:201","journal-title":"J Neuroinflammation"},{"key":"4866_CR78","doi-asserted-by":"publisher","first-page":"eade6900","DOI":"10.1126\/sciadv.ade6900","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Li J, Zhao Y, Huang Y, Shi Z, Wang H, Cao H, Wang C et al (2024) Arresting the bad seed: HDAC3 regulates proliferation of different microglia after ischemic stroke. Sci Adv 10:eade6900","journal-title":"Sci Adv"},{"key":"4866_CR79","doi-asserted-by":"publisher","first-page":"9644","DOI":"10.7150\/thno.47651","volume":"10","author":"Y Liao","year":"2020","unstructured":"Liao Y, Cheng J, Kong X, Li S, Li X, Zhang M, Zhang H, Yang T et al (2020) HDAC3 inhibition ameliorates ischemia\/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway. Theranostics 10:9644\u20139662","journal-title":"Theranostics"},{"key":"4866_CR80","doi-asserted-by":"publisher","first-page":"2241008","DOI":"10.1080\/15592294.2023.2241008","volume":"18","author":"L Meleady","year":"2023","unstructured":"Meleady L, Towriss M, Kim J, Bacarac V, Dang V, Rowland ME, Ciernia AV (2023) Histone deacetylase 3 regulates microglial function through histone deacetylation. Epigenetics 18:2241008","journal-title":"Epigenetics"},{"key":"4866_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s12035-022-03083-z","volume":"60","author":"H Lu","year":"2023","unstructured":"Lu H, Ashiqueali R, Lin CI, Walchale A, Clendaniel V, Matheson R, Fisher M, Lo EH et al (2023) Histone Deacetylase 3 inhibition decreases cerebral edema and protects the blood-brain barrier after stroke. Mol Neurobiol 60:235\u2013246","journal-title":"Mol Neurobiol"},{"key":"4866_CR82","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1096\/fj.201900394RRR","volume":"34","author":"MJ Zhang","year":"2020","unstructured":"Zhang MJ, Zhao QC, Xia MX, Chen J, Chen YT, Cao X, Liu Y, Yuan ZQ et al (2020) The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome. FASEB J 34:648\u2013662","journal-title":"FASEB J"},{"key":"4866_CR83","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1021\/acschemneuro.1c00826","volume":"13","author":"W Sun","year":"2022","unstructured":"Sun W, Zhang N, Liu B, Yang J, Loers G, Siebert HC, Wen M, Zheng X et al (2022) HDAC3 Inhibitor RGFP966 ameliorated neuroinflammation in the cuprizone-induced demyelinating mouse model and LPS-Stimulated BV2 Cells by Downregulating the P2X7R\/STAT3\/NF-kappaB65\/NLRP3 Activation. ACS Chem Neurosci 13:2579\u20132598","journal-title":"ACS Chem Neurosci"},{"key":"4866_CR84","doi-asserted-by":"publisher","first-page":"eabd8811","DOI":"10.1126\/sciadv.abd8811","volume":"7","author":"S Wahane","year":"2021","unstructured":"Wahane S, Zhou X, Zhou X, Guo L, Friedl MS, Kluge M, Ramakrishnan A, Shen L et al (2021) Diversified transcriptional responses of myeloid and glial cells in spinal cord injury shaped by HDAC3 activity. Sci Adv 7:eabd8811","journal-title":"Sci Adv"},{"key":"4866_CR85","doi-asserted-by":"publisher","first-page":"8641","DOI":"10.1038\/s41598-017-08535-4","volume":"7","author":"T Kuboyama","year":"2017","unstructured":"Kuboyama T, Wahane S, Huang Y, Zhou X, Wong JK, Koemeter-Cox A, Martini M, Friedel RH et al (2017) HDAC3 inhibition ameliorates spinal cord injury by immunomodulation. Sci Rep 7:8641","journal-title":"Sci Rep"},{"key":"4866_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152498","volume":"11","author":"H Jia","year":"2016","unstructured":"Jia H, Wang Y, Morris CD, Jacques V, Gottesfeld JM, Rusche JR, Thomas EA (2016) The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington\u2019s Disease Mice. PLoS ONE 11:e0152498","journal-title":"PLoS ONE"},{"key":"4866_CR87","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","volume":"21","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV (2018) The role of brain vasculature in neurodegenerative disorders. Nat Neurosci 21:1318\u20131331","journal-title":"Nat Neurosci"},{"key":"4866_CR88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","volume":"18","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Shue F, Bu G, Kanekiyo T (2023) Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease. Mol Neurodegener 18:46","journal-title":"Mol Neurodegener"},{"key":"4866_CR89","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR et al (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25:270","journal-title":"Nat Med"},{"key":"4866_CR90","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, Pachicano M, Joe E et al (2020) APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature 581:70","journal-title":"Nature"},{"key":"4866_CR91","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13024-021-00502-y","volume":"16","author":"B Nguyen","year":"2021","unstructured":"Nguyen B, Bix G, Yao Y (2021) Basal lamina changes in neurodegenerative disorders. Mol Neurodegener 16:81","journal-title":"Mol Neurodegener"},{"key":"4866_CR92","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fnins.2019.00864","volume":"13","author":"SM Stamatovic","year":"2019","unstructured":"Stamatovic SM, Phillips CM, Martinez-Revollar G, Keep RF, Andjelkovic AV (2019) Involvement of epigenetic mechanisms and non-coding RNAs in blood-brain barrier and neurovascular unit injury and recovery after stroke. Front Neurosci 13:864","journal-title":"Front Neurosci"},{"key":"4866_CR93","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1095\/biolreprod.110.087452","volume":"84","author":"P Mital","year":"2011","unstructured":"Mital P, Hinton BT, Dufour JM (2011) The blood-testis and blood-epididymis barriers are more than just their tight junctions. Biol Reprod 84:851\u2013858","journal-title":"Biol Reprod"},{"key":"4866_CR94","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301349RR","volume":"38","author":"M Liu","year":"2024","unstructured":"Liu M, He Q, Yuan Z, Chen N, Ren S, Du Q, Wang Y, Han S et al (2024) HDAC3 promotes Sertoli cell maturation and maintains the blood-testis barrier dynamics. FASEB J 38:e23526","journal-title":"FASEB J"},{"key":"4866_CR95","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12974-019-1495-3","volume":"16","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Zhang F, Yu Z, Guo S, Liu N, Jiang Y, Lo EH, Xu Y et al (2019) HDAC3 inhibition prevents blood-brain barrier permeability through Nrf2 activation in type 2 diabetes male mice. J Neuroinflammation 16:103","journal-title":"J Neuroinflammation"},{"key":"4866_CR96","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S2213-8587(19)30405-X","volume":"8","author":"TT van Sloten","year":"2020","unstructured":"van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8:325\u2013336","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4866_CR97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF02686117","volume":"31","author":"RS Broide","year":"2007","unstructured":"Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ (2007) Distribution of histone deacetylases 1\u201311 in the rat brain. J Mol Neurosci 31:47\u201358","journal-title":"J Mol Neurosci"},{"key":"4866_CR98","doi-asserted-by":"publisher","first-page":"773","DOI":"10.14336\/AD.2021.1116","volume":"13","author":"LP Jiang","year":"2022","unstructured":"Jiang LP, Yu XH, Chen JZ, Hu M, Zhang YK, Lin HL, Tang WY, He PP et al (2022) Histone deacetylase 3: a potential therapeutic target for atherosclerosis. Aging Dis 13:773\u2013786","journal-title":"Aging Dis"},{"key":"4866_CR99","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.3233\/JAD-170844","volume":"61","author":"L Yu","year":"2018","unstructured":"Yu L, Liu Y, Jin Y, Cao X, Chen J, Jin J, Gu Y, Bao X et al (2018) Lentivirus-Mediated HDAC3 inhibition attenuates oxidative stress in APPswe\/PS1dE9 Mice. J Alzheimers Dis 61:1411\u20131424","journal-title":"J Alzheimers Dis"},{"key":"4866_CR100","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.3390\/ijms24054805","volume":"24","author":"C Wang","year":"2023","unstructured":"Wang C, Shen D, Hu Y, Chen J, Liu J, Huang Y, Yu X, Chu H et al (2023) Selective targeting of class I HDAC reduces microglial inflammation in the entorhinal cortex of young APP\/PS1 mice. Int J Mol Sci 24:4805","journal-title":"Int J Mol Sci"},{"key":"4866_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126592","volume":"10","author":"KW Anderson","year":"2015","unstructured":"Anderson KW, Chen J, Wang M, Mast N, Pikuleva IA, Turko IV (2015) Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain. PLoS ONE 10:e0126592","journal-title":"PLoS ONE"},{"key":"4866_CR102","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3233\/JAD-220532","volume":"89","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wei D, Lv S, Wang L, An H, Shao W, Wang Y, Huang Y et al (2022) Scutellarin modulates the microbiota-gut-brain axis and improves cognitive impairment in APP\/PS1 Mice. J Alzheimers Dis 89:955\u2013975","journal-title":"J Alzheimers Dis"},{"key":"4866_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13024-023-00625-4","volume":"18","author":"Y Lin","year":"2023","unstructured":"Lin Y, Lin A, Cai L, Huang W, Yan S, Wei Y, Ruan X, Fang W et al (2023) ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer\u2019s disease. Mol Neurodegener 18:47","journal-title":"Mol Neurodegener"},{"key":"4866_CR104","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M et al (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129\u201310140","journal-title":"J Neurosci"},{"key":"4866_CR105","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1471-4159.2007.05147.x","volume":"105","author":"R Minkeviciene","year":"2008","unstructured":"Minkeviciene R, Ihalainen J, Malm T, Matilainen O, Keksa-Goldsteine V, Goldsteins G, Iivonen H, Leguit N et al (2008) Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP\/PS1 transgenic and wild-type mice. J Neurochem 105:584\u2013594","journal-title":"J Neurochem"},{"key":"4866_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13895","volume":"22","author":"D Marinho","year":"2023","unstructured":"Marinho D, Ferreira IL, Lorenzoni R, Cardoso SM, Santana I, Rego AC (2023) Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer\u2019s disease. Aging Cell 22:e13895","journal-title":"Aging Cell"},{"key":"4866_CR107","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301762RR","volume":"38","author":"N Davis","year":"2024","unstructured":"Davis N, Taylor B, Abelleira-Hervas L, Karimian-Marnani N, Aleksynas R, Syed N, Di Giovanni S, Palmisano I et al (2024) Histone deacetylase-3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer\u2019s disease models. FASEB J 38:e23659","journal-title":"FASEB J"},{"key":"4866_CR108","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JAD-150838","volume":"51","author":"K Krishna","year":"2016","unstructured":"Krishna K, Behnisch T, Sajikumar S (2016) Inhibition of histone deacetylase 3 restores amyloid-beta oligomer-induced plasticity deficit in hippocampal CA1 pyramidal neurons. J Alzheimers Dis 51:783\u2013791","journal-title":"J Alzheimers Dis"},{"key":"4866_CR109","doi-asserted-by":"publisher","first-page":"4811","DOI":"10.1007\/s12035-023-03373-0","volume":"60","author":"NR Ricciardi","year":"2023","unstructured":"Ricciardi NR, Modarresi F, Lohse I, Andrade NS, Newman IR, Brown JM, Borja C, Marples B et al (2023) Investigating the synergistic potential of low-dose HDAC3 inhibition and radiotherapy in alzheimer\u2019s disease models. Mol Neurobiol 60:4811\u20134827","journal-title":"Mol Neurobiol"},{"key":"4866_CR110","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/npp.2015.93","volume":"40","author":"G Rumbaugh","year":"2015","unstructured":"Rumbaugh G, Sillivan SE, Ozkan ED, Rojas CS, Hubbs CR, Aceti M, Kilgore M, Kudugunti S et al (2015) Pharmacological selectivity within class I histone deacetylases predicts effects on synaptic function and memory rescue. Neuropsychopharmacology 40:2307\u20132316","journal-title":"Neuropsychopharmacology"},{"key":"4866_CR111","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/ph15121481","volume":"15","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang C, Wang J, Huang Y, Shen D, Hu Y, Chu H, Yu X et al (2022) A Class I HDAC inhibitor BG45 alleviates cognitive impairment through the CaMKII\/ITPKA\/Ca(2+) signaling pathway. Pharmaceuticals (Basel) 15:1481","journal-title":"Pharmaceuticals (Basel)"},{"key":"4866_CR112","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Nance M, Ross CA et al (2015) Huntington disease. Nat Rev Dis Primers 1:15005","journal-title":"Nat Rev Dis Primers"},{"key":"4866_CR113","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1523\/JNEUROSCI.5831-12.2013","volume":"33","author":"FH Bardai","year":"2013","unstructured":"Bardai FH, Verma P, Smith C, Rawat V, Wang L, D\u2019Mello SR (2013) Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity. J Neurosci 33:11833\u201311838","journal-title":"J Neurosci"},{"key":"4866_CR114","doi-asserted-by":"publisher","first-page":"e31080","DOI":"10.1371\/journal.pone.0031080","volume":"7","author":"L Moumn\u00e9","year":"2012","unstructured":"Moumn\u00e9 L, Campbell K, Howland D, Ouyang YB, Bates GP (2012) Genetic knock-down of does not modify disease-related phenotypes in a mouse model of huntington\u2019s disease. Plos One 7:e31080","journal-title":"Plos One"},{"key":"4866_CR115","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1038\/s41598-017-05125-2","volume":"7","author":"N Suelves","year":"2017","unstructured":"Suelves N, Kirkham-McCarthy L, Lahue RS, Gines S (2017) A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington\u2019s disease mice. Sci Rep 7:6082","journal-title":"Sci Rep"},{"key":"4866_CR116","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BST20180462","volume":"47","author":"JH Kluss","year":"2019","unstructured":"Kluss JH, Mamais A, Cookson MR (2019) LRRK2 links genetic and sporadic Parkinson\u2019s disease. Biochem Soc Trans 47:651\u2013661","journal-title":"Biochem Soc Trans"},{"key":"4866_CR117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddx222","volume":"26","author":"KA Han","year":"2017","unstructured":"Han KA, Shin WH, Jung S, Seol W, Seo H, Ko C, Chung KC (2017) Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation. Hum Mol Genet 26:1\u201318","journal-title":"Hum Mol Genet"},{"key":"4866_CR118","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/biomedicines9101445","volume":"9","author":"S Demyanenko","year":"2021","unstructured":"Demyanenko S, Dzreyan V, Sharifulina S (2021) Histone deacetylases and their isoform-specific inhibitors in ischemic stroke. Biomedicines 9:1445","journal-title":"Biomedicines"},{"key":"4866_CR119","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1440-1681.2012.05729.x","volume":"39","author":"YT Chen","year":"2012","unstructured":"Chen YT, Zang XF, Pan J, Zhu XL, Chen F, Chen ZB, Xu Y (2012) Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection. Clin Exp Pharmacol Physiol 39:751\u2013758","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4866_CR120","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fnmol.2016.00131","volume":"9","author":"X Yang","year":"2016","unstructured":"Yang X, Wu Q, Zhang L, Feng L (2016) Inhibition of histone deacetylase 3 (HDAC3) mediates ischemic preconditioning and protects cortical neurons against ischemia in rats. Front Mol Neurosci 9:131","journal-title":"Front Mol Neurosci"},{"key":"4866_CR121","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s12975-020-00783-3","volume":"11","author":"R Matheson","year":"2020","unstructured":"Matheson R, Chida K, Lu H, Clendaniel V, Fisher M, Thomas A, Lo EH, Selim M et al (2020) Neuroprotective effects of selective inhibition of histone deacetylase 3 in experimental stroke. Transl Stroke Res 11:1052\u20131063","journal-title":"Transl Stroke Res"},{"key":"4866_CR122","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.bbi.2012.06.008","volume":"26","author":"A Kumar","year":"2012","unstructured":"Kumar A, Loane DJ (2012) Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 26:1191\u20131201","journal-title":"Brain Behav Immun"},{"key":"4866_CR123","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","volume":"9","author":"CK Donat","year":"2017","unstructured":"Donat CK, Scott G, Gentleman SM, Sastre M (2017) Microglial activation in traumatic brain injury. Front Aging Neurosci 9:208","journal-title":"Front Aging Neurosci"},{"key":"4866_CR124","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.2174\/1570159X22666240128002056","volume":"22","author":"L Ye","year":"2024","unstructured":"Ye L, Li W, Tang X, Xu T, Wang G (2024) Emerging neuroprotective strategies: unraveling the potential of HDAC inhibitors in traumatic brain injury management. Curr Neuropharmacol 22:2298","journal-title":"Curr Neuropharmacol"},{"key":"4866_CR125","doi-asserted-by":"publisher","first-page":"tkad062","DOI":"10.1093\/burnst\/tkad062","volume":"12","author":"L Xu","year":"2024","unstructured":"Xu L, An T, Jia B, Wu Q, Shen J, Jin J, Liu J, Li C (2024) Histone deacetylase 3-specific inhibitor RGFP966 attenuates oxidative stress and inflammation after traumatic brain injury by activating the Nrf2 pathway. Burns Trauma 12:tkad062","journal-title":"Burns Trauma"},{"key":"4866_CR126","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/npp.2009.197","volume":"35","author":"M Kilgore","year":"2010","unstructured":"Kilgore M, Miller CA, Fass DM, Hennig KM, Haggarty SJ, Sweatt JD, Rumbaugh G (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 35:870\u2013880","journal-title":"Neuropsychopharmacology"},{"key":"4866_CR127","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41467-019-13918-4","volume":"11","author":"A Cooper","year":"2020","unstructured":"Cooper A, Butto T, Hammer N, Jagannath S, Fend-Guella DL, Akhtar J, Radyushkin K, Lesage F et al (2020) Inhibition of histone deacetylation rescues phenotype in a mouse model of Birk-Barel intellectual disability syndrome. Nat Commun 11:480","journal-title":"Nat Commun"},{"key":"4866_CR128","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/jnc.14309","volume":"145","author":"EA Thomas","year":"2018","unstructured":"Thomas EA, D\u2019Mello SR (2018) Complex neuroprotective and neurotoxic effects of histone deacetylases. J Neurochem 145:96\u2013110","journal-title":"J Neurochem"},{"key":"4866_CR129","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuron.2008.10.015","volume":"60","author":"D Kim","year":"2008","unstructured":"Kim D, Frank CL, Dobbin MM, Tsunemoto RK, Tu W, Peng PL, Guan JS, Lee BH et al (2008) Deregulation of HDAC1 by p25\/Cdk5 in neurotoxicity. Neuron 60:803\u2013817","journal-title":"Neuron"},{"key":"4866_CR130","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1038\/s41467-020-16361-y","volume":"11","author":"PC Pao","year":"2020","unstructured":"Pao PC, Patnaik D, Watson LA, Gao F, Pan L, Wang J, Adaikkan C, Penney J et al (2020) HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer\u2019s disease. Nat Commun 11:2484","journal-title":"Nat Commun"},{"key":"4866_CR131","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1021\/acschemneuro.0c00308","volume":"12","author":"D Patnaik","year":"2021","unstructured":"Patnaik D, Pao PC, Zhao WN, Silva MC, Hylton NK, Chindavong PS, Pan L, Tsai LH et al (2021) Exifone is a potent HDAC1 activator with neuroprotective activity in human neuronal models of neurodegeneration. ACS Chem Neurosci 12:271\u2013284","journal-title":"ACS Chem Neurosci"},{"key":"4866_CR132","doi-asserted-by":"publisher","first-page":"100719","DOI":"10.1016\/j.colcom.2023.100719","volume":"55","author":"P Wang","year":"2023","unstructured":"Wang P, Geng JW, Tan CY, Wei Q (2023) Substrate stiffness dominants cell gene expression via regulation of HDAC3 subcellular localization. Colloid Interfac Sci 55:100719","journal-title":"Colloid Interfac Sci"},{"key":"4866_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18160","volume":"9","author":"HP Gu","year":"2023","unstructured":"Gu HP, Wu XF, Gong YT, Mu-Yao W, Shi MY, Sun YM, Dang BQ, Chen G (2023) RGFP966 exerts neuroprotective effect via HDAC3\/Nrf2 pathway after surgical brain injury in rats. Heliyon 9:e18160","journal-title":"Heliyon"},{"key":"4866_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.nlm.2020.107367","volume":"178","author":"AA Keiser","year":"2021","unstructured":"Keiser AA, Kramar EA, Dong T, Shanur S, Pirodan M, Ru N, Acharya MM, Baulch JE et al (2021) Systemic HDAC3 inhibition ameliorates impairments in synaptic plasticity caused by simulated galactic cosmic radiation exposure in male mice. Neurobiol Learn Mem 178:107367","journal-title":"Neurobiol Learn Mem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04866-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04866-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04866-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:43:09Z","timestamp":1757155389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04866-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":134,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4866"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04866-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"The authors report no disclosure.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}